ResearcherShanxi Provincial Cancer HospitalActive in the last 2 years

Xiuxiu Li

ORCID-verified (high confidence)As of 11 November 2026

Matched on ORCID iD 0000-0002-2733-9843; OpenAlex author ID A5014406366.

Their work

Papers: 2 (first author 2, last author 0)
Trials: 0
Grants: 0
Collaborators: 1

Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

Corrigendum to "Injectable anticancer biodegradable hydrogel-based nanocomposites: Synergistic pH-responsive paclitaxel/β-cyclodextrin nanocomplex delivery in … First author DOI 10.1016/j.ijpharm.2025.126475 ↗
Injectable anticancer biodegradable hydrogel-based nanocomposites: Synergistic pH-responsive paclitaxel/β-cyclodextrin nanocomplex delivery in polyvinyl alcoho… First author DOI 10.1016/j.ijpharm.2025.125514 ↗

Closest collaborators

The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

A. I. Ismail · 2 shared papers, 2025–2026
- Paper Corrigendum to "Injectable anticancer biodegradable hydrogel-based nanocomposites: Synergistic pH-responsive paclitaxel… DOI 10.1016/j.ijpharm.2025.126475 ↗
- Paper Injectable anticancer biodegradable hydrogel-based nanocomposites: Synergistic pH-responsive paclitaxel/β-cyclodextrin … DOI 10.1016/j.ijpharm.2025.125514 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.